Sulbactam/Durlobactam.

Authors :: Beninger P
Source :: Clinical therapeutics [Clin Ther] 2024 Jan; Vol. 46 (1), pp. 82-83. Date of Electronic Publication: 2023 Dec 07.
Publication Year :: 2024
Abstract: Competing Interests: Declaration of Competing Interest Paul Beninger receives a salary as a faculty member in the department of Public Health & Community Medicine at Tufts University School of Medicine. He also received compensation as a topic editor for Clinical Therapeutics (Elsevier) 2016-2022 and presently as Co-Editor-in-Chief, beginning in 2022; and as a training consultant for small pharmaceutical companies in 2020-2022. The author has indicated that he has no other conflicts of interest regarding the content of this article.